Minister of Health and Social Welfare, Prof Muhammad Ali Pate has confirmed that the Ebola index patient on Monday morning departed Abuja for Switzerland following his approval.

In a massage posted on his X handle, Pate noted that the index patient has clinically much improved, stable, conscious, communicating, and with her clinical laboratory test results closing towards baseline.Airport officials cordoned off the private wing of the airport but ARISE News eventually obtained videos of a medivac plane with crews eventually evacuating the sick passenger suspected to be the Ebola index case due to the special nature of the medical evacuation.

A source told ARISE News that the Federal Government will make the announcement of the medical evacuation only after the plane has taken off and exited the Nigerian airspace.

The Federal Government on October , 20, 2026 , announced a confirmation of one case of Ebola disease in the Federal Capital Territory (FCT), following laboratory confirmation.

The patient, a woman who recently arrived in Nigeria on an international flight from Uganda, was admitted to a private hospital in the FCT, where she received care for several days before the diagnosis was confirmed.

The Nigeria Centre for Disease Control and Prevention (NCDC) has identified one new suspected case of Ebola Virus in Rivers State which has tested negative .

As at October , 25, 2026, a total of 53 contacts have been identified and placed under public health surveillance with most of them under quarantine.

Director-General of the NCDC, Dr Jide Idris on Sunday disclosed the index patient’s samples had been tested repeatedly and remained positive, while samples from the patient’s husband returned negative results.

He explained that the FCT remains the only state with a confirmed case, while the suspected case identified in Rivers state tested negative .

Idris stated that the identified contacts included healthcare workers, domestic staff, the patient’s spouse and other individuals who might have been exposed during the course of medical care, sample collection or other relevant interactions.